Theratechnologies inc.

Theratechnologies inc.

March 24, 2009 09:26 ET

Theratechnologies: Annual and Special Meeting of Shareholders

MONTREAL, CANADA--(Marketwire - March 24, 2009) - Mr. Paul Pommier, Chairman of the Board of Theratechnologies (TSX:TH) and Mr. Yves Rosconi, President and Chief Executive Officer, invite shareholders to Theratechnologies' Annual and Special Meeting that will be held on Thursday, March 26, 2009, at 10:00 a.m., at the Sheraton Center Montreal, 1201 Rene-Levesque Blvd. West, in Montreal.

What: Theratechnologies' Annual and Special Meeting of Shareholders

When: Thursday, March 26, 2009 at 10:00 a.m.

Where: The Sheraton Center Montreal
1201 Rene-Levesque Blvd. West, Montreal
Drummond Room

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in specialty markets. Its most advanced compound, tesamorelin, is an analogue of the growth hormone releasing factor. In 2008, Theratechnologies completed a confirmatory Phase 3 clinical trial evaluating tesamorelin in treating excess abdominal fat in HIV patients with lipodystrophy, a serious metabolic disorder. The Company also has other projects at earlier stages of development.

Contact Information